Di Nuzzo Private Wealth, Inc. Acadia Pharmaceuticals Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $697 Million
- Q3 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 12 shares of ACAD stock, worth $272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$272% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
353Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$974 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$274 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$204 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$140 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.67B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...